PRECIGEN, INC. 8-K

What Happened

• Precigen, Inc. (PGEN) filed an 8-K reporting results of its June 18, 2026 annual meeting. Stockholders re-elected the company’s slate of directors for one-year terms, ratified Deloitte & Touche LLP as independent auditor for FY2026, approved a non-binding advisory vote on executive compensation, and approved an amendment to the Precigen 2023 Omnibus Incentive Plan to add 7,000,000 shares (the “2023 Plan Amendment No. 3”). The full text of the plan amendment was included in the company’s proxy filing.

Key Details

• 2023 Plan Amendment No. 3: approved to increase the number of shares available under the 2023 Omnibus Incentive Plan by 7,000,000 shares; full text attached to the company’s proxy.
• Director elections: Randal Kirk, Nancy Howell Agee, Cesar Alvarez, Steven Frank, Vinita Gupta, Fred Hassan, Jeffrey Kindler, Helen Sabzevari, and James Turley were elected to one-year terms. Example vote totals: Randal Kirk — 207,060,147 for; Helen Sabzevari — 210,626,763 for; Vinita Gupta — 153,104,242 for, 57,856,824 against.
• Auditor ratification: Deloitte & Touche LLP ratified as independent registered public accounting firm for fiscal 2026 (272,813,907 for; 253,969 against; 671,783 abstain).
• Executive pay advisory vote: approved (208,241,739 for; 2,790,879 against; 1,254,232 abstain). For the plan amendment vote: 207,056,264 for; 4,996,260 against; 234,326 abstain; broker non-votes reported at 61,452,809.

Why It Matters

• The 7 million-share increase to the equity incentive plan gives the company flexibility to grant stock-based awards to employees, executives and directors; when awards are granted or exercised those shares could dilute existing shareholders.
• Re-election of the full board and ratification of the auditor signal governance continuity. The advisory “say-on-pay” vote passed, which is non-binding but indicates shareholder approval of executive compensation as disclosed.
• Investors should note the plan amendment and vote tallies (including sizable broker non-votes) when assessing potential dilution and governance support.